LLY

Eli Lilly and Company

HealthcareDrug Manufacturers - GeneralUSUSD

$1,081.96

+0.20%LiveJun 01, 2026

Market cap

$1.02T

52w range

623.78 – 1149.10

P / E

—

EPS

—

Volume

2.04M

Revenue · FY

$65.18B

+44.70% YoY

Explain this page

Arphra AIPlain-English read on Eli Lilly and Company’s valuation

DB · stock_splits4

Date	Ratio	Type	Multiplier
Oct 16, 1997	2-for-1	Forward	2.00×
Dec 21, 1995	2-for-1	Forward	2.00×
May 01, 1989	2-for-1	Forward	2.00×
Jan 30, 1986	2-for-1	Forward	2.00×

1DB

Whole-company transactions where LLY is acquirer or target.

Date	Role	Counterparty	Filing
Dec 19, 2003	Acquirer	Eli Lilly	SEC →

DB · 13D/G24

Filed	Form	Reporter	% owned	Shares
Jul 07, 2023	—	ELI LILLY AND COMPANY	40.30%	—	SEC →
Jul 07, 2023	—	SHENANDOAH ACQUISITION CORPORATION	31.90%	—	SEC →
Oct 27, 2022	—	KEARNY ACQUISITION CORPORATION	25.50%	—	SEC →
Oct 27, 2022	—	ELI LILLY AND COMPANY	25.50%	—	SEC →
Feb 11, 2022	—	42-1604685	0.01%	—	SEC →
Feb 11, 2022	—	51-0326854	5.42%	—	SEC →
Feb 11, 2022	—	22-1146430	5.42%	—	SEC →
Feb 11, 2022	—	Inc. 25-1435979	5.42%	—	SEC →
Feb 11, 2022	—	81-0581990	0.01%	—	SEC →
Feb 10, 2022	—	Eli Lilly and Company	0.70%	—	SEC →
Feb 10, 2022	—	Eli Lilly and Company	3.10%	—	SEC →
Feb 10, 2022	—	Eli Lilly and Company	3.50%	—	SEC →
Feb 10, 2022	—	Eli Lilly and Company	5.80%	—	SEC →
Feb 10, 2022	—	Eli Lilly S.A.	5.80%	—	SEC →
Feb 10, 2022	—	Eli Lilly and Company	3.50%	—	SEC →
Feb 10, 2022	—	Lilly Ventures Fund I LLC	3.50%	—	SEC →
Feb 10, 2022	—	Lilly Ventures Fund I LLC	3.10%	—	SEC →
Feb 10, 2022	—	Eli Lilly and Company	4.90%	—	SEC →
Feb 10, 2022	—	Lilly Ventures Fund I LLC	0.70%	—	SEC →
Feb 09, 2022	—	The Vanguard Group - 23-1945930	7.24%	—	SEC →
Feb 08, 2022	—	(1) BlackRock, Inc.	6.70%	—	SEC →
Jan 27, 2022	—	LILLY ENDOWMENT INC	11.23%	—	SEC →
Dec 13, 2021	—	OR	9.70%	—	SEC →
Sep 10, 2021	—	35-0470950	5.60%	—	SEC →

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.